JP2007507458A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007507458A5 JP2007507458A5 JP2006530072A JP2006530072A JP2007507458A5 JP 2007507458 A5 JP2007507458 A5 JP 2007507458A5 JP 2006530072 A JP2006530072 A JP 2006530072A JP 2006530072 A JP2006530072 A JP 2006530072A JP 2007507458 A5 JP2007507458 A5 JP 2007507458A5
- Authority
- JP
- Japan
- Prior art keywords
- beads
- onto
- formulation
- subcoating
- sprayed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 2
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000009498 subcoating Methods 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0323202A GB0323202D0 (en) | 2003-10-03 | 2003-10-03 | Organic compounds |
| GB0323598A GB0323598D0 (en) | 2003-10-08 | 2003-10-08 | Organic compounds |
| GB0329852A GB0329852D0 (en) | 2003-12-23 | 2003-12-23 | Organic compounds |
| GB0405902A GB0405902D0 (en) | 2004-03-16 | 2004-03-16 | Organic compounds |
| GB0410714A GB0410714D0 (en) | 2004-05-13 | 2004-05-13 | Organic compounds |
| GB0419356A GB0419356D0 (en) | 2004-08-31 | 2004-08-31 | Organic compounds |
| PCT/EP2004/010998 WO2005034916A1 (en) | 2003-10-03 | 2004-10-01 | Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007507458A JP2007507458A (ja) | 2007-03-29 |
| JP2007507458A5 true JP2007507458A5 (enExample) | 2007-11-22 |
Family
ID=34437795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530072A Pending JP2007507458A (ja) | 2003-10-03 | 2004-10-01 | ミコフェノール酸またはミコフェノール酸ナトリウムを含む医薬多粒子組成物およびラパマイシンとの組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070036857A1 (enExample) |
| EP (1) | EP1670437A1 (enExample) |
| JP (1) | JP2007507458A (enExample) |
| AR (1) | AR045957A1 (enExample) |
| AU (1) | AU2004280078B2 (enExample) |
| BR (1) | BRPI0414864A (enExample) |
| CA (1) | CA2538099A1 (enExample) |
| MX (1) | MXPA06003646A (enExample) |
| PE (1) | PE20050755A1 (enExample) |
| TW (1) | TW200520759A (enExample) |
| WO (1) | WO2005034916A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1478648B1 (en) | 2002-02-01 | 2014-04-30 | ARIAD Pharmaceuticals, Inc. | Phosphorus-containing compounds and uses thereof |
| GB0419355D0 (en) * | 2004-08-31 | 2004-09-29 | Novartis Ag | Organic compounds |
| WO2006086498A2 (en) * | 2005-02-08 | 2006-08-17 | Aspreva Pharmaceuticals Sa | Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors |
| GB0523659D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| KR20080094788A (ko) * | 2006-02-13 | 2008-10-24 | 노파르티스 아게 | 고복용량의 미코페놀산(엠피에이) |
| CA2669415A1 (en) * | 2006-11-14 | 2008-05-22 | Ariad Pharmaceuticals, Inc. | Solid dosage form comprising ap23573 |
| AU2008288106B2 (en) * | 2007-08-13 | 2012-03-15 | Panacea Biotec Limited | Extended release compositions comprising mycophenolate sodium and processes thereof |
| CN101969931A (zh) * | 2008-03-05 | 2011-02-09 | 万能药生物有限公司 | 包含霉酚酸的调节释放药物组合物及其方法 |
| EP2446027A1 (en) * | 2009-06-25 | 2012-05-02 | Danisco A/S | Protein |
| EA201270544A1 (ru) * | 2009-10-13 | 2012-09-28 | Тева Фармасьютикал Индастриз Лтд. | Композиции с отсроченным высвобождением |
| US10391059B2 (en) | 2009-11-11 | 2019-08-27 | Rapamycin Holdings, Inc. | Oral rapamycin nanoparticle preparations and use |
| US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
| EP2763663B1 (en) * | 2011-10-06 | 2017-12-27 | Novartis AG | Pharmaceutical compositions comprising 40-o-(2-hydroxy)ethyl-rapamycin |
| JP2015533174A (ja) * | 2012-10-11 | 2015-11-19 | セラヴィダ，インコーポレイテッド | ピロカルピンの医薬製剤 |
| TW201503912A (zh) | 2013-03-19 | 2015-02-01 | Novartis Ag | 包含癌莫事（ｅｖｅｒｏｌｉｍｕｓ）之醫藥組合物 |
| WO2014167442A1 (en) * | 2013-03-26 | 2014-10-16 | Wockhardt Limited | Pharmaceutical compositions comprising mycophenolic acid or salts thereof |
| US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
| HUP1400075A2 (hu) | 2014-02-14 | 2015-08-28 | Druggability Technologies Ip Holdco Jersey Ltd | Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói |
| MA40982A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
| US10576076B2 (en) | 2015-05-20 | 2020-03-03 | Novartis Ag | Pharmaceutical combination of everolimus with dactolisib |
| JP2020500930A (ja) | 2016-11-23 | 2020-01-16 | ノバルティス アーゲー | エベロリムス、ダクトリシブまたは両方で免疫応答を増強する方法 |
| MX2019010829A (es) * | 2017-03-13 | 2020-02-05 | Okava Pharmaceuticals Inc | Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos. |
| WO2019157516A1 (en) | 2018-02-12 | 2019-08-15 | resTORbio, Inc. | Combination therapies |
| US11446055B1 (en) | 2018-10-18 | 2022-09-20 | Lumoptik, Inc. | Light assisted needle placement system and method |
| US20250282721A9 (en) * | 2021-12-23 | 2025-09-11 | Gencaps Sàrl | Drug delivery system comprising monomethyl fumarate |
| WO2023224914A1 (en) * | 2022-05-16 | 2023-11-23 | Mayo Foundation For Medical Education And Research | Assessing and treating caveolinopathy diseases |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2086642C (en) * | 1992-01-09 | 2004-06-15 | Randall E. Morris | Method of treating hyperproliferative vascular disease |
| US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
| US5283257A (en) * | 1992-07-10 | 1994-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating hyperproliferative vascular disease |
| PL177323B1 (pl) * | 1993-10-01 | 1999-10-29 | Syntex Inc | Kompozycja farmaceutyczna zawierająca mykofenolan mofetylu lub kwas mykofenolowy i sposób wytwarzania kompozycji farmaceutycznej zawierającej mykofenolan mofetylu lub kwas mykofenolowy |
| ID18663A (id) * | 1996-04-12 | 1998-04-30 | Novartis Ag | Komposisi farmasi berlapis enterik |
| CN1233169A (zh) * | 1996-10-14 | 1999-10-27 | 弗·哈夫曼-拉罗切有限公司 | 一种粉末状制剂的制备工艺 |
| US6890546B2 (en) * | 1998-09-24 | 2005-05-10 | Abbott Laboratories | Medical devices containing rapamycin analogs |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| WO2000067773A2 (en) * | 1999-05-10 | 2000-11-16 | Novartis Ag | Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| GB0124953D0 (en) * | 2001-10-17 | 2001-12-05 | Novartis Ag | Organic Compounds |
| JP2005514411A (ja) * | 2002-01-10 | 2005-05-19 | ノバルティス アクチエンゲゼルシャフト | ラパマイシンおよびその誘導体を含む血管疾患の予防および処置用薬剤送達システム |
| SI1539157T1 (sl) * | 2002-09-18 | 2013-11-29 | Trustees Of The University Of Pennsylvania | Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije |
| CA2500908A1 (en) * | 2002-10-04 | 2004-04-22 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
| GB0301259D0 (en) * | 2003-01-20 | 2003-02-19 | Novartis Ag | Organic compounds |
| GB0307553D0 (en) * | 2003-04-01 | 2003-05-07 | Novartis Ag | Organic compounds |
-
2004
- 2004-09-30 AR ARP040103556A patent/AR045957A1/es unknown
- 2004-10-01 AU AU2004280078A patent/AU2004280078B2/en not_active Ceased
- 2004-10-01 BR BRPI0414864-9A patent/BRPI0414864A/pt not_active IP Right Cessation
- 2004-10-01 PE PE2004000963A patent/PE20050755A1/es not_active Application Discontinuation
- 2004-10-01 JP JP2006530072A patent/JP2007507458A/ja active Pending
- 2004-10-01 US US10/570,752 patent/US20070036857A1/en not_active Abandoned
- 2004-10-01 TW TW093129854A patent/TW200520759A/zh unknown
- 2004-10-01 WO PCT/EP2004/010998 patent/WO2005034916A1/en not_active Ceased
- 2004-10-01 EP EP04765757A patent/EP1670437A1/en not_active Withdrawn
- 2004-10-01 MX MXPA06003646A patent/MXPA06003646A/es not_active Application Discontinuation
- 2004-10-01 CA CA002538099A patent/CA2538099A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007014631A3 (de) | Substrat, umfassend zumindest eine voll- oder teilflächige makrostrukturierte schicht, verfahren zu deren herstellung und deren verwendung | |
| JP2005526058A5 (enExample) | ||
| WO2010042951A3 (en) | Anti-reflective coatings comprising ordered layers of nanowires and methods of making and using the same | |
| WO2005091835A3 (en) | A method and system for making a coated medical device | |
| WO2006044810A3 (en) | Surgical fasteners coated with wound treatment materials | |
| GB0513803D0 (en) | Fabric care composition | |
| DE602006002095D1 (de) | Antireflexschichtzusammensetzung, Musterungsverfahren und diese verwendendes Substrat | |
| WO2006014930A3 (en) | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation | |
| WO2008093346A3 (en) | Compositions for topical application comprising a peroxide and retinoid | |
| WO2004069135A3 (en) | Composition comprising a mixture of active principles, and method of preparation | |
| DE50205419D1 (de) | Verfahren zur Herstellung von Kieselsäure mit homogener Silyliermittelschicht | |
| JP2008512527A5 (enExample) | ||
| WO2020141789A3 (ko) | 점착제 조성물, 이를 포함하는 점착제층 및 이를 포함하는 폴더블 디스플레이 | |
| GB2364317B (en) | Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof | |
| WO2009122187A3 (en) | Pharmaceutical composition | |
| EP1589082A4 (en) | COATING COMPOSITION, ANTI-REFLECTION FILM, PHOTOLACK, AND PATTERN BASED THIS PRINTING METHOD | |
| TW200630242A (en) | Decorative pattern and its preparation | |
| TW200621331A (en) | Method and kit for forming an outside layer on a curved surface | |
| WO2013126874A3 (en) | Seed coating composition and related methods | |
| EP2093613A4 (en) | SUPERIOR SURFACE ANTIREFLECTION FILM COMPOSITION, AND PATTERN FORMATION METHOD USING THE SAME | |
| WO2009013356A3 (en) | Anti-hiv tablet formulations comprising darunavir | |
| JP2005522729A5 (enExample) | ||
| AU2003221135A1 (en) | New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof | |
| GB2374078B (en) | Organic anti-reflective coating polymers, anti-reflective coating composition comprising the same and preparation methods thereof | |
| JP2009522138A5 (enExample) |